9:22 AM
Leo Group India
| ||
| Pharmaceutical company to pay $95M to settle allegations of improper drug ... Washington Post WASHINGTON — Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle allegations that the company promoted three drugs for uses that were not medically accepted, the government announced Thursday. The Justice Department said the ... See all stories on this topic » | ||
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Teva Receives Approval For ... 4-traders Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) approved SYNRIBO (omacetaxine mepesuccinate) for Injection to treat adult patients with chronic phase (CP) or accelerated phase (AP) ... See all stories on this topic » | ||
| ||
| SAP ERP Project Manager - Pharmaceutical Company - London The Independent This pharmaceutical organisation is embarking on an ambitious transformational programme of work to implement a new SAP ERP system across the business. This Pharmaceutical Company are looking to achieve a challenging target that will require them to ... See all stories on this topic » | ||
| 5 Pharmaceutical Stocks to Buy Now Investorplace.com This week, five Pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). Johnson & Johnson (NYSE:JNJ) is making progress this week as its rating of C ... See all stories on this topic » | ||
| Sun Pharma MD's brother-in-law to buy stake in Telenor Business Standard Promoters of Indian pharmaceutical companies are busy with diversifying their businesses into new areas. After Ajay Piramal's investment into Vodafone India, another pharmaceuticals veteran - Sudhir Valia, promoter of Sun Pharmaceuticals and ... See all stories on this topic » | ||
| Overcharging set to cost pharma companies full sales revenue of drug Economic Times ... entire sale amount from the date of introduction of the product till issue of the price notification order shall be recovered from the company, treating the entire sale proceeds as 'unauthorised sales'," the National Pharmaceutical Pricing ... See all stories on this topic » | ||
| BioMarin Pharmaceutical Management Discusses Q3 2012 Results - Earnings ... Seeking Alpha This nonconfidential presentation contains forward-looking statements about the business prospects of BioMarin Pharmaceutical, including expectations regarding BioMarin's financial performance, commercial products and potential future products in ... See all stories on this topic » | ||
| TORRENT PHARMACEUTICALS LIMITED : Torrent Pharma records 13% growth ... 4-traders Ahmedabad-based Torrent Pharmaceuticals Limited, today released its financial results for the quarter ended 30th September, 2012. The Q2' 12-13 revenues stood at Rs. 777 crores, up by 13% from Rs. 685 crores in the comparable quarter of last year. See all stories on this topic » | ||
| BioMed Realty Announces 80500 Square Foot Lease Expansion For Regeneron ... Sacramento Bee BioMed Realty delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty owns or has interests in ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment